Authors
Latest:
Dr. Glitza on Intrathecal Nivolumab Approaches in Leptomeningeal DiseaseIsabella C. Glitza, MD, discusses a single-center phase I/Ib trial of concurrent intravenous and intrathecal nivolumab for patients with metastatic melanoma and leptomeningeal disease.
Latest:
Dr. Turkbey on Sodium Fluoride PET Imaging for Prostate CancerIsmail Baris Turkbey, MD, staff clinician in the Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, discusses sodium fluoride PET imaging for patients with prostate cancer.
Latest:
Voice Recognition Systems Save Time and MoneyDue to a variety of factors, today’s oncologists face multiple challenges in collecting, managing, and sharing their patients’ health data.
Latest:
Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple MyelomaIvan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.
Latest:
Dr. Altomare on Investigational Agents in ITPIvy P. Altomare, MD, discusses investigational agents in immune thrombocytopenia.
Latest:
Dr. Lossos on Research Questions in MCLIzidore S. Lossos, MD, professor, director, Lymphoma Program Head of hematological malignancies site disease group, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses research questions in the field of mantle cell lymphoma (MCL).
Latest:
Dr. Rizzo on Impact of Age on Survival Outcomes in MDS After HCTJ. Douglas Rizzo, MD, MS, assistant scientific professor, Center for International Blood and Marrow Transplant Research, professor of Medicine, Medical College of Wisconsin, discusses a study that examined if age affects survival outcomes in patients with myelodysplastic syndromes who receive a hematopoietic cell transplant.
Latest:
Dr. Parsons Discusses the Link Between Exercise and Bladder Cancer RiskJ. Kellogg Parsons, MD, associate professor of surgery (urology), University of California, San Diego, discusses modifiable lifestyle factors associated with bladder cancer.
Latest:
Dr. Dixon on Prevalence and Risk Factors of Male Breast CancerJ. Michael Dixon, MD, professor of Surgery, consultant surgeon, and clinical director of the Breakthrough Breast Cancer Research Unit at the University of Edinburgh in Scotland, discusses the prevalence of and risk factors for breast cancer in males.
Latest:
Dr. Davis on Comparisons Between Robotic Surgery and Open Surgery in Lung CancerJ. Russell Davis, MD, clinical professor, University of Missouri–Kansas City School of Medicine, thoracic surgeon, Saint Luke's Hospital, compares the use of robotic surgery with open surgery in patients with lung cancer.
Latest:
Ranking Value in Cancer Care: Analysis of a "Pathways" ApproachAmid a continuing debate over healthcare spending in the United States, the oncology community is growing more introspective about the costs associated with increasingly sophisticated cancer therapeutics.
Latest:
Dr. Roth Compares Surgery With SBRT in Lung CancerJack A. Roth, MD, professor, Department of Thoracic and Cardiovascular Surgery, chief, Section of Thoracic Molecular Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, compares surgery with stereotactic body radiation therapy (SBRT) in patients with early-stage lung cancer.
Latest:
Effective Management and Prevention of Neratinib-Induced DiarrheaSafety data from clinical trials suggest that a prophylactic regimen reduces both the severity and duration of neratinib-associated diarrhea.
Latest:
Plan Now for MIPS Reporting in 2018The end of the year is always hectic for oncology practices, but 2017 is proving exceptionally busy as CMS' Quality Payment Program transitional year comes to a close.
Latest:
Jacob Gersh Discusses the CyberKnifeJacob Gersh, PhD, lead physicist at the Gibbs Cancer Center & Research Institute, discusses the CyberKnife.
Latest:
Dr. Laubach on the Efficacy of Daratumumab in MyelomaJacob Laubach, MD, MPP, from Dana-Farber Cancer Institute, discusses responses observed following the administration of daratumumab for patients with multiple myeloma.
